🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Anthropometric, Functional and Lifestyle Factors Associated With Testosterone Levels in Middle-Aged Men

Recruitingn/aAges 35 Years - 59 YearsMaleAndijan State Medical Institute
NCT07476222 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Decreased testosterone levels in middle-aged men are associated with multiple metabolic, functional and psychosocial consequences. Early identification of modifiable factors associated with reduced testosterone levels may facilitate the early identification of men at increased risk of testosterone deficiency and support preventive healthcare strategies. This population-based cross-sectional observational study aims to investigate anthropometric, functional and lifestyle-related factors associated with serum total testosterone levels in middle-aged men. Approximately 600 men aged 35-59 years residing in the Andijan region of Uzbekistan will be recruited. Participants will undergo comprehensive assessment including anthropometric measurements, functional performance tests, standardised questionnaires and laboratory determination of serum total testosterone concentrations. Anthropometric

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Men aged 35-59 years * Permanent residence in the Andijan region of Uzbekistan * Ability and willingness to provide written informed consent * Willingness to undergo clinical, anthropometric, functional and laboratory assessments Exclusion Criteria: * Previously diagnosed hypogonadism requiring testosterone replacement therapy * Current use of testosterone preparations or other medications known to substantially affect androgen status * Severe cardiovascular, hepatic or renal disease in the stage of decompensation * Clinically significant urological pathology * Severe psychiatric illness or cognitive impairment limiting study participation * Acute infectious or inflammatory conditions at the time of assessment
💊

What it tests

  • Observational Assessment
📍

Where

1 site
Andijan State Medical Institute
Andijan, Uzbekistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy